Charles Schwab’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.4M Buy
310,486
+30,913
+11% +$2.27M ﹤0.01% 1653
2025
Q4
$19M Buy
279,573
+739
+0.3% +$46.2K ﹤0.01% 1778
2025
Q3
$15.9M Buy
278,834
+1,282
+0.5% +$76K ﹤0.01% 1874
2025
Q2
$15.4M Buy
277,552
+1,426
+0.5% +$66.9K ﹤0.01% 1804
2025
Q1
$12.1M Sell
276,126
-5,532
-2% -$241K ﹤0.01% 1862
2024
Q4
$12.1M Buy
281,658
+2,565
+0.9% +$116K ﹤0.01% 1931
2024
Q3
$12.5M Buy
279,093
+4,155
+2% +$172K ﹤0.01% 1928
2024
Q2
$10.6M Buy
274,938
+61,073
+29% +$2.33M ﹤0.01% 2018
2024
Q1
$7.37M Buy
213,865
+6,149
+3% +$197K ﹤0.01% 2144
2023
Q4
$6.01M Buy
+207,716
New +$4.74M ﹤0.01% 2227

Other funds holding DBD

Charles Schwab's DBD Position: Q1 2026 in Review

Charles Schwab increased its Diebold Nixdorf (DBD) stake by 11% in Q1 2026, buying an estimated $2.27M and bringing the position to 310,486 shares worth $23.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Charles Schwab first reported a position in DBD in Q4 2023 and has held it in 10 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Charles Schwab held 310,486 shares of Diebold Nixdorf worth $23.4M as of Q1 2026.
  • Charles Schwab bought 30,913 Diebold Nixdorf shares in Q1 2026, an estimated $2.27M.
  • Diebold Nixdorf made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #1653 holding.
  • Charles Schwab first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 10 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.